Apolipoprotein e LDL receptor-binding domain-containing high-density lipoprotein: A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 1, 2011, Pages 352-359

  Khumsupan, Panupon ^a   Ramirez, Ricardo ^a   Khumsupan, Darin ^a   Narayanaswami, Vasanthy ^a,b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Anti amyloid; Apolipoprotein E; Curcumin; Fluorescence; High density lipoprotein; Nanodisc; Nanovehicle

Indexed keywords

APOLIPOPROTEIN E; CURCUMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHOLIPID;

ARTICLE; BINDING SITE; CELL SURFACE; CHOLESTEROL TRANSPORT; DRUG STRUCTURE; ELECTRON MICROSCOPY; HYDROPHOBICITY; LIGAND BINDING; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PHOSPHOLIPID BILAYER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

AMYLOID; ANTIOXIDANTS; APOLIPOPROTEINS E; BINDING SITES; CURCUMIN; DRUG DELIVERY SYSTEMS; FLAVONOIDS; HUMANS; LIPOPROTEINS, HDL; MODELS, CHEMICAL; NANOTECHNOLOGY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, LDL; SPECTROPHOTOMETRY;

EID: 78649762660     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.09.007     Document Type: Article

References (60)

1. G.J. Kelloff, C.W. Boone, J.A. Crowell, V.E. Steele, R.A. Lubet, L.A. Doody, W.F. Malone, E.T. Hawk, and C.C. Sigman New agents for cancer chemoprevention J. Cell. Biochem. Suppl. 26 1996 1 28
2. R.A. Sharma, A.J. Gescher, and W.P. Steward Curcumin: the story so far Eur. J. Cancer. 41 2005 1955 1968
3. K. Ono, K. Hasegawa, H. Naiki, and M. Yamada Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro J. Neurosci. Res. 75 2004 742 750
4. F. Yang, G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, S.S. Ambegaokar, P.P. Chen, R. Kayed, C.G. Glabe, S.A. Frautschy, and G.M. Cole Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J. Biol. Chem. 280 2005 5892 5901
5. G.P. Lim, T. Chu, F. Yang, W. Beech, S.A. Frautschy, and G.M. Cole The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J. Neurosci. 21 2001 8370 8377
6. M. Garcia-Alloza, L.A. Borrelli, A. Rozkalne, B.T. Hyman, and B.J. Bacskai Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model J. Neurochem. 102 2007 1095 1104
7. B. Wahlstrom, and G. Blennow A study on the fate of curcumin in the rat Acta Pharmacol. Toxicol. (Copenh) 43 1978 86 92
8. V. Ravindranath, and N. Chandrasekhara Metabolism of curcumin-studies with [3H]curcumin Toxicology 22 1981 337 344
9. M.H. Pan, T.M. Huang, and J.K. Lin Biotransformation of curcumin through reduction and glucuronidation in mice Drug Metab. Dispos. 27 1999 486 494
10. C. Ireson, S. Orr, D.J. Jones, R. Verschoyle, C.K. Lim, J.L. Luo, L. Howells, S. Plummer, R. Jukes, M. Williams, W.P. Steward, and A. Gescher Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production Cancer Res. 61 2001 1058 1064
11. C.R. Ireson, D.J. Jones, S. Orr, M.W. Coughtrie, D.J. Boocock, M.L. Williams, P.B. Farmer, W.P. Steward, and A.J. Gescher Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine Cancer Epidemiol. Biomarkers. Prev. 11 2002 105 111
12. R.A. Sharma, C.R. Ireson, R.D. Verschoyle, K.A. Hill, M.L. Williams, C. Leuratti, M.M. Manson, L.J. Marnett, W.P. Steward, and A. Gescher Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels Clin. Cancer Res. 7 2001 1452 1458
13. S. Lund-Katz, and M.C. Phillips High density lipoprotein structure-function and role in reverse cholesterol transport Subcell. Biochem. 51 2010 183 227
14. V. Narayanaswami, R.S. Kiss, and P.M. Weers The helix bundle: a reversible lipid binding motif Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 155 2010 123 133
15. E.P. de Chaves, and V. Narayanaswami Apolipoprotein E and cholesterol in aging and disease in the brain Future Lipidol. 3 2008 505 530
16. R.W. Mahley, Y. Huang, and K.H. Weisgraber Putting cholesterol in its place: apoE and reverse cholesterol transport J. Clin. Invest. 116 2006 1226 1229
17. C. Wilson, M.R. Wardell, K.H. Weisgraber, R.W. Mahley, and D.A. Agard Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E Science 252 1991 1817 1822
18. K.H. Weisgraber Apolipoprotein E: structure-function relationships Adv. Protein Chem. 45 1994 249 302
19. C.D. Mamotte, M. Sturm, J.I. Foo, F.M. van Bockxmeer, and R.R. Taylor Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes Am. J. Physiol. 276 1999 E553 E557
20. R.E. Pitas, J.K. Boyles, S.H. Lee, D. Foss, and R.W. Mahley Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins Biochim. Biophys. Acta. 917 1987 148 161
21. A. Lalazar, K.H. Weisgraber, S.C. Rall Jr., H. Giladi, T.L. Innerarity, A.Z. Levanon, J.K. Boyles, B. Amit, M. Gorecki, and R.W. Mahley Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions J. Biol. Chem. 263 1988 3542 3545
22. V. Gupta, V. Narayanaswami, M.S. Budamagunta, T. Yamamato, J.C. Voss, and R.O. Ryan Lipid-induced extension of apolipoprotein E helix 4 correlates with low density lipoprotein receptor binding ability J. Biol. Chem. 281 2006 39294 39299
23. N. Choy, V. Raussens, and V. Narayanaswami Inter-molecular coiled-coil formation in human apolipoprotein E C-terminal domain J. Mol. Biol. 334 2003 527 539
24. V. Narayanaswami, J.N. Maiorano, P. Dhanasekaran, R.O. Ryan, M.C. Phillips, S. Lund-Katz, and W.S. Davidson Helix orientation of the functional domains in apolipoprotein e in discoidal high density lipoprotein particles J. Biol. Chem. 279 2004 14273 14279
25. D.L. Sparks, and M.C. Phillips Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis J. Lipid. Res. 33 1992 123 130
26. T.M. Forte, J.K. Bielicki, R. Goth-Goldstein, J. Selmek, and M.R. McCall Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT J. Lipid Res. 36 1995 148 157
27. O. Gursky, Ranjana, and D.L. Gantz Complex of human apolipoprotein C-1 with phospholipid: thermodynamic or kinetic stability? Biochemistry 41 2002 7373 7384
28. S. Tamamizu-Kato, M.G. Kosaraju, H. Kato, V. Raussens, J.M. Ruysschaert, and V. Narayanaswami Calcium-triggered membrane interaction of the alpha-synuclein acidic tail Biochemistry 45 2006 10947 10956
29. J.R. Lakowicz Quenching of Fluorescence, and Advanced Topics in Fluorescence Quenching. Principles of Fluorescence Spectroscopy 1999 Kluwer Academic/Plenum New York pp. 238-289
30. D. Sahoo, V. Narayanaswami, C.M. Kay, and R.O. Ryan Pyrene excimer fluorescence: a spatially sensitive probe to monitor lipid-induced helical rearrangement of apolipophorin III Biochemistry 39 2000 6594 6601
31. M.R. Eftink, and C.A. Ghiron Exposure of tryptophanyl residues in proteins Quantitative determination by fluorescence quenching studies, Biochemistry 15 1976 672 680
32. S. Tamamizu-Kato, J.Y. Wong, V. Jairam, K. Uchida, V. Raussens, H. Kato, J.M. Ruysschaert, and V. Narayanaswami Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E Biochemistry 46 2007 8392 8400
33. C. Fisher, D. Abdul-Aziz, and S.C. Blacklow A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands Biochemistry 43 2004 1037 1044
34. S.T. Kunitake, K.J. La Sala, and J.P. Kane Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility J. Lipid. Res. 26 1985 549 555
35. B.Y. Ishida, J. Frolich, and C.J. Fielding Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer J. Lipid. Res. 28 1987 778 786
36. V. Raussens, V. Narayanaswami, E. Goormaghtigh, R.O. Ryan, and J.M. Ruysschaert Alignment of the apolipophorin-III alpha-helices in complex with dimyristoylphosphatidylcholine. A unique spatial orientation J. Biol. Chem. 270 1995 12542 12547
37. J. Drury, and V. Narayanaswami Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence J. Biol. Chem. 280 2005 14605 14610
38. C.A. Fisher, V. Narayanaswami, and R.O. Ryan The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E J. Biol. Chem. 275 2000 33601 33606
39. J.R. Lakowicz Protein Fluorescence 1999 Kluwer Academic / Plenum Publishers, New York Principles of Fluorescence Spectroscopy pp. 445-486
40. J.H. Wald, E. Coormaghtigh, J. De Meutter, J.M. Ruysschaert, and A. Jonas Investigation of the lipid domains and apolipoprotein orientation in reconstituted high density lipoproteins by fluorescence and IR methods J. Biol. Chem. 265 1990 20044 20050
41. A.V. Nichols, E.L. Gong, P.J. Blanche, and T.M. Forte Characterization of discoidal complexes of phosphatidylcholine, apolipoprotein A-I and cholesterol by gradient gel electrophoresis Biochim. Biophys. Acta 750 1983 353 364
42. R.E. Pitas, T.L. Innerarity, and R.W. Mahley Cell surface receptor binding of phospholipid. protein complexes containing different ratios of receptor-active and -inactive E apoprotein J. Biol. Chem. 255 1980 5454 5460
43. B. Dehouck, L. Fenart, M.P. Dehouck, A. Pierce, G. Torpier, and R. Cecchelli A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier J. Cell Biol. 138 1997 877 889
44. T.H. Bayburt, J.W. Carlson, and S.G. Sligar Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer J. Struct. Biol. 123 1998 37 44
45. A. Nath, W.M. Atkins, and S.G. Sligar Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins Biochemistry 46 2007 2059 2069
46. J. Borch, and T. Hamann The nanodisc: a novel tool for membrane protein studies Biol. Chem. 390 2009 805 814
47. T.S. Nguyen, P.M. Weers, V. Raussens, Z. Wang, G. Ren, T. Sulchek, P.D. Hoeprich Jr., and R.O. Ryan Amphotericin B induces interdigitation of apolipoprotein stabilized nanodisk bilayers Biochim. Biophys. Acta. 1778 2008 303 312
48. V. Narayanaswami, S.S. Szeto, and R.O. Ryan Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3 J. Biol. Chem. 276 2001 37853 37860
49. F. Bao, H. Arai, S. Matsushita, S. Higuchi, and H. Sasaki Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain Neuroreport 7 1996 1733 1739
50. A.M. Fagan, D.M. Holtzman, G. Munson, T. Mathur, D. Schneider, L.K. Chang, G.S. Getz, C.A. Reardon, J. Lukens, J.A. Shah, and M.J. LaDu Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice J. Biol. Chem. 274 1999 30001 30007
51. M.F. Linton, R. Gish, S.T. Hubl, E. Butler, C. Esquivel, W.I. Bry, J.K. Boyles, M.R. Wardell, and S.G. Young Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation J. Clin. Invest. 88 1991 270 281
52. J.M. Dietschy, and S.D. Turley Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal J. Lipid Res. 45 2004 1375 1397
53. M.H. Leung, and T.W. Kee Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen Langmuir 25 2009 5773 5777
54. A. Barik, K.I. Priyadarsini, and H. Mohan Photophysical studies on binding of curcumin to bovine serum albumins Photochem. Photobiol. 77 2003 597 603
55. A.C. Pulla Reddy, E. Sudharshan, A.G. Appu Rao, and B.R. Lokesh Interaction of curcumin with human serum albumin-a spectroscopic study Lipids 34 1999 1025 1029
56. C. Castelluccio, G.P. Bolwell, C. Gerrish, and C. Rice-Evans Differential distribution of ferulic acid to the major plasma constituents in relation to its potential as an antioxidant Biochem. J. 316 1996 691 694
57. M.T. Huang, W. Ma, Y.P. Lu, R.L. Chang, C. Fisher, P.S. Manchand, H.L. Newmark, and A.H. Conney Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13- acetate-induced tumor promotion Carcinogenesis 16 1995 2493 2497
58. S.K. Sandur, M.K. Pandey, B. Sung, K.S. Ahn, A. Murakami, G. Sethi, P. Limtrakul, V. Badmaev, and B.B. Aggarwal Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism Carcinogenesis 28 2007 1765 1773
59. G.K. Jayaprakasha, L. Jaganmohan Rao, and K.K. Sakariah Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin Food Chemistry 98 2006 720 724
60. S. Khanna, H.A. Park, C.K. Sen, T. Golakoti, K. Sengupta, S. Venkateswarlu, and S. Roy Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid Antioxid. Redox Signal 11 2009 449 468